Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review

26 Aug 2020

Abstract excerpt

Clinical research in high-income countries is increasingly demonstrating the cost- effectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of adverse drug reactions and improving overall patient care. Medications are prescribed based on an individual's genotype (pharmacogenes), which underlies a specific phenotypic drug response. The advent of cost-effective high-throughput genotyping...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmaceutical studies and practices
Share to Pharmacogenetics and Drug Metabolism

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32858798
DOI: 10.3390/pharmaceutics12090809

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical ReviewPMID 32858798Read ↗

Pharmacogenomics in Africa: A Potential Catalyst for Precision Medicine in Genetically Diverse Populations.Semantic proximity Read ↗

African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in AfricaSemantic proximity Read ↗

A Review of Clinical Pharmacogenetics Studies in African PopulationsSemantic proximity Read ↗

An Update to the Clinical Pharmacogenetics Implementation Consortium (CPIC) SLCO1B1 Allele Functionality Table Leveraging Evidence from Participants of Predominantly Sub-Saharan African Ancestry.Semantic proximity Read ↗

One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?Semantic proximity Read ↗

Applying an equity lens to pharmacogenetic research and translation to under-represented populations.Semantic proximity Read ↗

Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.Semantic proximity Read ↗

Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry.Semantic proximity Read ↗

Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa.Semantic proximity Read ↗

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.Semantic proximity Read ↗

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesSemantic proximity Read ↗

The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.